Impact of COVID-19 Outbreak on Vaccine for Influenza, Global Market Research Report 2020
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Vaccine for Influenza market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Vaccine for Influenza industry.
Segment by Type, the Vaccine for Influenza market is segmented into
The Vaccine for Influenza market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Vaccine for Influenza market report are:
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Vaccine for Influenza market include:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Vaccine for Influenza market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Vaccine for Influenza industry.
Segment by Type, the Vaccine for Influenza market is segmented into
- Trivalent Influenza Vaccine
- Quadrivalent Influenza Vaccine
- For Children (6 months to 3 years)
- For Adults and Children over 3 years
The Vaccine for Influenza market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Vaccine for Influenza market report are:
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- U.A.E
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Vaccine for Influenza market include:
- Sanofi
- CSL
- GSK
- Mylan
- Hulan Bio
- AstraZeneca
- CCBIO
1 VACCINE FOR INFLUENZA MARKET OVERVIEW
1.1 Product Overview and Scope of Vaccine for Influenza
1.2 Covid-19 Impact on Vaccine for Influenza Segment by Type
1.2.1 Global Vaccine for Influenza Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Covid-19 Impact on Vaccine for Influenza Segment by Application
1.3.1 Vaccine for Influenza Sales Comparison by Application: 2020 VS 2026
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Covid-19 Impact on Global Vaccine for Influenza Market Size Estimates and Forecasts
1.4.1 Global Vaccine for Influenza Revenue 2015-2026
1.4.2 Global Vaccine for Influenza Sales 2015-2026
1.4.3 Vaccine for Influenza Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Vaccine for Influenza Industry
1.7 COVID-19 Impact: Vaccine for Influenza Market Trends
2 COVID-19 IMPACT ON GLOBAL VACCINE FOR INFLUENZA MARKET COMPETITION BY MANUFACTURERS
2.1 Global Vaccine for Influenza Sales Market Share by Manufacturers (2015-2020)
2.2 Global Vaccine for Influenza Revenue Share by Manufacturers (2015-2020)
2.3 Global Vaccine for Influenza Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Vaccine for Influenza Manufacturing Sites, Area Served, Product Type
2.5 Vaccine for Influenza Market Competitive Situation and Trends
2.5.1 Vaccine for Influenza Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Vaccine for Influenza Players (Opinion Leaders)
3 COVID-19 IMPACT ON VACCINE FOR INFLUENZA RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Vaccine for Influenza Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Vaccine for Influenza Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Vaccine for Influenza Market Facts & Figures by Country
3.3.1 North America Vaccine for Influenza Sales by Country
3.3.2 North America Vaccine for Influenza Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Vaccine for Influenza Market Facts & Figures by Country
3.4.1 Europe Vaccine for Influenza Sales by Country
3.4.2 Europe Vaccine for Influenza Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Vaccine for Influenza Market Facts & Figures by Region
3.5.1 Asia Pacific Vaccine for Influenza Sales by Region
3.5.2 Asia Pacific Vaccine for Influenza Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Vaccine for Influenza Market Facts & Figures by Country
3.6.1 Latin America Vaccine for Influenza Sales by Country
3.6.2 Latin America Vaccine for Influenza Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Vaccine for Influenza Market Facts & Figures by Country
3.7.1 Middle East and Africa Vaccine for Influenza Sales by Country
3.7.2 Middle East and Africa Vaccine for Influenza Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 COVID-19 IMPACT ON GLOBAL VACCINE FOR INFLUENZA HISTORIC MARKET ANALYSIS BY TYPE
4.1 Global Vaccine for Influenza Sales Market Share by Type (2015-2020)
4.2 Global Vaccine for Influenza Revenue Market Share by Type (2015-2020)
4.3 Global Vaccine for Influenza Price Market Share by Type (2015-2020)
4.4 Global Vaccine for Influenza Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 COVID-19 IMPACT ON GLOBAL VACCINE FOR INFLUENZA HISTORIC MARKET ANALYSIS BY APPLICATION
5.1 Global Vaccine for Influenza Sales Market Share by Application (2015-2020)
5.2 Global Vaccine for Influenza Revenue Market Share by Application (2015-2020)
5.3 Global Vaccine for Influenza Price by Application (2015-2020)
6 COMPANY PROFILES AND KEY FIGURES IN VACCINE FOR INFLUENZA BUSINESS
6.1 Sanofi
6.1.1 Corporation Information
6.1.2 Sanofi Description, Business Overview and Total Revenue
6.1.3 Sanofi Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Sanofi Products Offered
6.1.5 Sanofi Recent Development and Response to COVID-19
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description, Business Overview and Total Revenue
6.2.3 CSL Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
6.2.4 CSL Products Offered
6.2.5 CSL Recent Development and Response to COVID-19
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description, Business Overview and Total Revenue
6.3.3 GSK Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
6.3.4 GSK Products Offered
6.3.5 GSK Recent Development and Response to COVID-19
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Description, Business Overview and Total Revenue
6.4.3 Mylan Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Mylan Products Offered
6.4.5 Mylan Recent Development and Response to COVID-19
6.5 Hulan Bio
6.5.1 Hulan Bio Corporation Information
6.5.2 Hulan Bio Description, Business Overview and Total Revenue
6.5.3 Hulan Bio Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Hulan Bio Products Offered
6.5.5 Hulan Bio Recent Development and Response to COVID-19
6.6 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description, Business Overview and Total Revenue
6.6.3 AstraZeneca Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
6.6.4 AstraZeneca Products Offered
6.6.5 AstraZeneca Recent Development and Response to COVID-19
6.7 CCBIO
6.6.1 CCBIO Corporation Information
6.6.2 CCBIO Description, Business Overview and Total Revenue
6.6.3 CCBIO Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
6.4.4 CCBIO Products Offered
6.7.5 CCBIO Recent Development and Response to COVID-19
7 VACCINE FOR INFLUENZA MANUFACTURING COST ANALYSIS
7.1 Vaccine for Influenza Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Vaccine for Influenza
7.4 Vaccine for Influenza Industrial Chain Analysis
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
8.1 Marketing Channel
8.2 Vaccine for Influenza Distributors List
8.3 Vaccine for Influenza Customers
9 MARKET DYNAMICS
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 GLOBAL MARKET FORECAST
10.1 Global Vaccine for Influenza Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Vaccine for Influenza by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Vaccine for Influenza by Type (2021-2026)
10.2 Vaccine for Influenza Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Vaccine for Influenza by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Vaccine for Influenza by Application (2021-2026)
10.3 Vaccine for Influenza Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Vaccine for Influenza by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Vaccine for Influenza by Region (2021-2026)
10.4 North America Vaccine for Influenza Estimates and Projections (2021-2026)
10.5 Europe Vaccine for Influenza Estimates and Projections (2021-2026)
10.6 Asia Pacific Vaccine for Influenza Estimates and Projections (2021-2026)
10.7 Latin America Vaccine for Influenza Estimates and Projections (2021-2026)
10.8 Middle East and Africa Vaccine for Influenza Estimates and Projections (2021-2026)
11 RESEARCH FINDING AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
1.1 Product Overview and Scope of Vaccine for Influenza
1.2 Covid-19 Impact on Vaccine for Influenza Segment by Type
1.2.1 Global Vaccine for Influenza Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Covid-19 Impact on Vaccine for Influenza Segment by Application
1.3.1 Vaccine for Influenza Sales Comparison by Application: 2020 VS 2026
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Covid-19 Impact on Global Vaccine for Influenza Market Size Estimates and Forecasts
1.4.1 Global Vaccine for Influenza Revenue 2015-2026
1.4.2 Global Vaccine for Influenza Sales 2015-2026
1.4.3 Vaccine for Influenza Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Vaccine for Influenza Industry
1.7 COVID-19 Impact: Vaccine for Influenza Market Trends
2 COVID-19 IMPACT ON GLOBAL VACCINE FOR INFLUENZA MARKET COMPETITION BY MANUFACTURERS
2.1 Global Vaccine for Influenza Sales Market Share by Manufacturers (2015-2020)
2.2 Global Vaccine for Influenza Revenue Share by Manufacturers (2015-2020)
2.3 Global Vaccine for Influenza Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Vaccine for Influenza Manufacturing Sites, Area Served, Product Type
2.5 Vaccine for Influenza Market Competitive Situation and Trends
2.5.1 Vaccine for Influenza Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Vaccine for Influenza Players (Opinion Leaders)
3 COVID-19 IMPACT ON VACCINE FOR INFLUENZA RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Vaccine for Influenza Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Vaccine for Influenza Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Vaccine for Influenza Market Facts & Figures by Country
3.3.1 North America Vaccine for Influenza Sales by Country
3.3.2 North America Vaccine for Influenza Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Vaccine for Influenza Market Facts & Figures by Country
3.4.1 Europe Vaccine for Influenza Sales by Country
3.4.2 Europe Vaccine for Influenza Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Vaccine for Influenza Market Facts & Figures by Region
3.5.1 Asia Pacific Vaccine for Influenza Sales by Region
3.5.2 Asia Pacific Vaccine for Influenza Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Vaccine for Influenza Market Facts & Figures by Country
3.6.1 Latin America Vaccine for Influenza Sales by Country
3.6.2 Latin America Vaccine for Influenza Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Vaccine for Influenza Market Facts & Figures by Country
3.7.1 Middle East and Africa Vaccine for Influenza Sales by Country
3.7.2 Middle East and Africa Vaccine for Influenza Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 COVID-19 IMPACT ON GLOBAL VACCINE FOR INFLUENZA HISTORIC MARKET ANALYSIS BY TYPE
4.1 Global Vaccine for Influenza Sales Market Share by Type (2015-2020)
4.2 Global Vaccine for Influenza Revenue Market Share by Type (2015-2020)
4.3 Global Vaccine for Influenza Price Market Share by Type (2015-2020)
4.4 Global Vaccine for Influenza Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 COVID-19 IMPACT ON GLOBAL VACCINE FOR INFLUENZA HISTORIC MARKET ANALYSIS BY APPLICATION
5.1 Global Vaccine for Influenza Sales Market Share by Application (2015-2020)
5.2 Global Vaccine for Influenza Revenue Market Share by Application (2015-2020)
5.3 Global Vaccine for Influenza Price by Application (2015-2020)
6 COMPANY PROFILES AND KEY FIGURES IN VACCINE FOR INFLUENZA BUSINESS
6.1 Sanofi
6.1.1 Corporation Information
6.1.2 Sanofi Description, Business Overview and Total Revenue
6.1.3 Sanofi Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Sanofi Products Offered
6.1.5 Sanofi Recent Development and Response to COVID-19
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description, Business Overview and Total Revenue
6.2.3 CSL Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
6.2.4 CSL Products Offered
6.2.5 CSL Recent Development and Response to COVID-19
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description, Business Overview and Total Revenue
6.3.3 GSK Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
6.3.4 GSK Products Offered
6.3.5 GSK Recent Development and Response to COVID-19
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Description, Business Overview and Total Revenue
6.4.3 Mylan Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Mylan Products Offered
6.4.5 Mylan Recent Development and Response to COVID-19
6.5 Hulan Bio
6.5.1 Hulan Bio Corporation Information
6.5.2 Hulan Bio Description, Business Overview and Total Revenue
6.5.3 Hulan Bio Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Hulan Bio Products Offered
6.5.5 Hulan Bio Recent Development and Response to COVID-19
6.6 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description, Business Overview and Total Revenue
6.6.3 AstraZeneca Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
6.6.4 AstraZeneca Products Offered
6.6.5 AstraZeneca Recent Development and Response to COVID-19
6.7 CCBIO
6.6.1 CCBIO Corporation Information
6.6.2 CCBIO Description, Business Overview and Total Revenue
6.6.3 CCBIO Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
6.4.4 CCBIO Products Offered
6.7.5 CCBIO Recent Development and Response to COVID-19
7 VACCINE FOR INFLUENZA MANUFACTURING COST ANALYSIS
7.1 Vaccine for Influenza Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Vaccine for Influenza
7.4 Vaccine for Influenza Industrial Chain Analysis
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
8.1 Marketing Channel
8.2 Vaccine for Influenza Distributors List
8.3 Vaccine for Influenza Customers
9 MARKET DYNAMICS
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 GLOBAL MARKET FORECAST
10.1 Global Vaccine for Influenza Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Vaccine for Influenza by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Vaccine for Influenza by Type (2021-2026)
10.2 Vaccine for Influenza Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Vaccine for Influenza by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Vaccine for Influenza by Application (2021-2026)
10.3 Vaccine for Influenza Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Vaccine for Influenza by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Vaccine for Influenza by Region (2021-2026)
10.4 North America Vaccine for Influenza Estimates and Projections (2021-2026)
10.5 Europe Vaccine for Influenza Estimates and Projections (2021-2026)
10.6 Asia Pacific Vaccine for Influenza Estimates and Projections (2021-2026)
10.7 Latin America Vaccine for Influenza Estimates and Projections (2021-2026)
10.8 Middle East and Africa Vaccine for Influenza Estimates and Projections (2021-2026)
11 RESEARCH FINDING AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
LIST OF TABLES
Table 1. Global Vaccine for Influenza Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Vaccine for Influenza Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Vaccine for Influenza Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. COVID-19 Impact Global Market: (Four Vaccine for Influenza Market Size Forecast Scenarios)
Table 5. Opportunities and Trends for Vaccine for Influenza Players in the COVID-19 Landscape
Table 6. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 7. Key Regions/Countries Measures against Covid-19 Impact
Table 8. Proposal for Vaccine for Influenza Players to Combat Covid-19 Impact
Table 9. Global Key Vaccine for Influenza Manufacturers Covered in This Study
Table 10. Global Vaccine for Influenza Sales (K Units) by Manufacturers (2015-2020)
Table 11. Global Vaccine for Influenza Sales Share by Manufacturers (2015-2020)
Table 12. Global Vaccine for Influenza Revenue (Million USD) by Manufacturers (2015-2020)
Table 13. Global Vaccine for Influenza Revenue Share by Manufacturers (2015-2020)
Table 14. Global Market Vaccine for Influenza Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 15. Manufacturers Vaccine for Influenza Sales Sites and Area Served
Table 16. Manufacturers Vaccine for Influenza Product Types
Table 17. Global Vaccine for Influenza Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 18. Global Vaccine for Influenza by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccine for Influenza as of 2019)
Table 19.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 20. Main Points Interviewed from Key Vaccine for Influenza Players
Table 21. Global Vaccine for Influenza Sales (K Units) by Region (2015-2020)
Table 22. Global Vaccine for Influenza Sales Market Share by Region (2015-2020)
Table 23. Global Vaccine for Influenza Revenue (Million US$) by Region (2015-2020)
Table 24. Global Vaccine for Influenza Revenue Market Share by Region (2015-2020)
Table 25. North America Vaccine for Influenza Sales by Country (2015-2020) (K Units)
Table 26. North America Vaccine for Influenza Sales Market Share by Country (2015-2020)
Table 27. North America Vaccine for Influenza Revenue by Country (2015-2020) (US$ Million)
Table 28. North America Vaccine for Influenza Revenue Market Share by Country (2015-2020)
Table 29. Europe Vaccine for Influenza Sales by Country (2015-2020) (K Units)
Table 30. Europe Vaccine for Influenza Sales Market Share by Country (2015-2020)
Table 31. Europe Vaccine for Influenza Revenue by Country (2015-2020) (US$ Million)
Table 32. Europe Vaccine for Influenza Revenue Market Share by Country (2015-2020)
Table 33. Asia Pacific Vaccine for Influenza Sales by Region (2015-2020) (K Units)
Table 34. Asia Pacific Vaccine for Influenza Sales Market Share by Region (2015-2020)
Table 35. Asia Pacific Vaccine for Influenza Revenue by Region (2015-2020) (US$ Million)
Table 36. Asia Pacific Vaccine for Influenza Revenue Market Share by Region (2015-2020)
Table 37. Latin America Vaccine for Influenza Sales by Country (2015-2020) (K Units)
Table 38. Latin America Vaccine for Influenza Sales Market Share by Country (2015-2020)
Table 39. Latin America Vaccine for Influenza Revenue by Country (2015-2020) (US$ Million)
Table 40. Latin America Vaccine for Influenza Revenue Market Share by Country (2015-2020)
Table 41. Middle East and Africa Vaccine for Influenza Sales by Country (2015-2020) (K Units)
Table 42. Middle East and Africa Vaccine for Influenza Sales Market Share by Country (2015-2020)
Table 43. Middle East and Africa Vaccine for Influenza Revenue by Country (2015-2020) (US$ Million)
Table 44. Middle East and Africa Vaccine for Influenza Revenue Market Share by Country (2015-2020)
Table 45. Global Vaccine for Influenza Sales (K Units) by Type (2015-2020)
Table 46. Global Vaccine for Influenza Sales Share by Type (2015-2020)
Table 47. Global Vaccine for Influenza Revenue (Million US$) by Type (2015-2020)
Table 48. Global Vaccine for Influenza Revenue Share by Type (2015-2020)
Table 49. Global Vaccine for Influenza Price (US$/Unit) by Type (2015-2020)
Table 50. Global Vaccine for Influenza Sales (K Units) by Application (2015-2020)
Table 51. Global Vaccine for Influenza Sales Market Share by Application (2015-2020)
Table 52. Global Vaccine for Influenza Sales Growth Rate by Application (2015-2020)
Table 53. Sanofi Vaccine for Influenza Corporation Information
Table 54. Sanofi Description and Business Overview
Table 55. Sanofi Vaccine for Influenza Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. Sanofi Main Product
Table 57. Sanofi Recent Development
Table 58. CSL Vaccine for Influenza Corporation Information
Table 59. CSL Corporation Information
Table 60. CSL Vaccine for Influenza Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. CSL Main Product
Table 62. CSL Recent Development
Table 63. GSK Vaccine for Influenza Corporation Information
Table 64. GSK Corporation Information
Table 65. GSK Vaccine for Influenza Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. GSK Main Product
Table 67. GSK Recent Development
Table 68. Mylan Vaccine for Influenza Corporation Information
Table 69. Mylan Corporation Information
Table 70. Mylan Vaccine for Influenza Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Mylan Main Product
Table 72. Mylan Recent Development
Table 73. Hulan Bio Vaccine for Influenza Corporation Information
Table 74. Hulan Bio Corporation Information
Table 75. Hulan Bio Vaccine for Influenza Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. Hulan Bio Main Product
Table 77. Hulan Bio Recent Development
Table 78. AstraZeneca Vaccine for Influenza Corporation Information
Table 79. AstraZeneca Corporation Information
Table 80. AstraZeneca Vaccine for Influenza Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. AstraZeneca Main Product
Table 82. AstraZeneca Recent Development
Table 83. CCBIO Vaccine for Influenza Corporation Information
Table 84. CCBIO Corporation Information
Table 85. CCBIO Vaccine for Influenza Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. CCBIO Main Product
Table 87. CCBIO Recent Development
Table 88. Sales Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Vaccine for Influenza Distributors List
Table 91. Vaccine for Influenza Customers List
Table 92. Market Key Trends
Table 93. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 94. Key Challenges
Table 95. Global Vaccine for Influenza Sales (K Units) Forecast by Type (2021-2026)
Table 96. Global Vaccine for Influenza Sales Market Share Forecast by Type (2021-2026)
Table 97. Global Vaccine for Influenza Revenue (Million US$) Forecast by Type (2021-2026)
Table 98. Global Vaccine for Influenza Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 99. Global Vaccine for Influenza Sales (K Units) Forecast by Application (2021-2026)
Table 100. Global Vaccine for Influenza Revenue (Million US$) Forecast by Application (2021-2026)
Table 101. Global Vaccine for Influenza Sales (K Units) Forecast by Region (2021-2026)
Table 102. Global Vaccine for Influenza Sales Market Share Forecast by Region (2021-2026)
Table 103. Global Vaccine for Influenza Revenue Forecast by Region (2021-2026) (US$ Million)
Table 104. Global Vaccine for Influenza Revenue Market Share Forecast by Region (2021-2026)
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
Table 1. Global Vaccine for Influenza Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Vaccine for Influenza Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Vaccine for Influenza Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. COVID-19 Impact Global Market: (Four Vaccine for Influenza Market Size Forecast Scenarios)
Table 5. Opportunities and Trends for Vaccine for Influenza Players in the COVID-19 Landscape
Table 6. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 7. Key Regions/Countries Measures against Covid-19 Impact
Table 8. Proposal for Vaccine for Influenza Players to Combat Covid-19 Impact
Table 9. Global Key Vaccine for Influenza Manufacturers Covered in This Study
Table 10. Global Vaccine for Influenza Sales (K Units) by Manufacturers (2015-2020)
Table 11. Global Vaccine for Influenza Sales Share by Manufacturers (2015-2020)
Table 12. Global Vaccine for Influenza Revenue (Million USD) by Manufacturers (2015-2020)
Table 13. Global Vaccine for Influenza Revenue Share by Manufacturers (2015-2020)
Table 14. Global Market Vaccine for Influenza Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 15. Manufacturers Vaccine for Influenza Sales Sites and Area Served
Table 16. Manufacturers Vaccine for Influenza Product Types
Table 17. Global Vaccine for Influenza Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 18. Global Vaccine for Influenza by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccine for Influenza as of 2019)
Table 19.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 20. Main Points Interviewed from Key Vaccine for Influenza Players
Table 21. Global Vaccine for Influenza Sales (K Units) by Region (2015-2020)
Table 22. Global Vaccine for Influenza Sales Market Share by Region (2015-2020)
Table 23. Global Vaccine for Influenza Revenue (Million US$) by Region (2015-2020)
Table 24. Global Vaccine for Influenza Revenue Market Share by Region (2015-2020)
Table 25. North America Vaccine for Influenza Sales by Country (2015-2020) (K Units)
Table 26. North America Vaccine for Influenza Sales Market Share by Country (2015-2020)
Table 27. North America Vaccine for Influenza Revenue by Country (2015-2020) (US$ Million)
Table 28. North America Vaccine for Influenza Revenue Market Share by Country (2015-2020)
Table 29. Europe Vaccine for Influenza Sales by Country (2015-2020) (K Units)
Table 30. Europe Vaccine for Influenza Sales Market Share by Country (2015-2020)
Table 31. Europe Vaccine for Influenza Revenue by Country (2015-2020) (US$ Million)
Table 32. Europe Vaccine for Influenza Revenue Market Share by Country (2015-2020)
Table 33. Asia Pacific Vaccine for Influenza Sales by Region (2015-2020) (K Units)
Table 34. Asia Pacific Vaccine for Influenza Sales Market Share by Region (2015-2020)
Table 35. Asia Pacific Vaccine for Influenza Revenue by Region (2015-2020) (US$ Million)
Table 36. Asia Pacific Vaccine for Influenza Revenue Market Share by Region (2015-2020)
Table 37. Latin America Vaccine for Influenza Sales by Country (2015-2020) (K Units)
Table 38. Latin America Vaccine for Influenza Sales Market Share by Country (2015-2020)
Table 39. Latin America Vaccine for Influenza Revenue by Country (2015-2020) (US$ Million)
Table 40. Latin America Vaccine for Influenza Revenue Market Share by Country (2015-2020)
Table 41. Middle East and Africa Vaccine for Influenza Sales by Country (2015-2020) (K Units)
Table 42. Middle East and Africa Vaccine for Influenza Sales Market Share by Country (2015-2020)
Table 43. Middle East and Africa Vaccine for Influenza Revenue by Country (2015-2020) (US$ Million)
Table 44. Middle East and Africa Vaccine for Influenza Revenue Market Share by Country (2015-2020)
Table 45. Global Vaccine for Influenza Sales (K Units) by Type (2015-2020)
Table 46. Global Vaccine for Influenza Sales Share by Type (2015-2020)
Table 47. Global Vaccine for Influenza Revenue (Million US$) by Type (2015-2020)
Table 48. Global Vaccine for Influenza Revenue Share by Type (2015-2020)
Table 49. Global Vaccine for Influenza Price (US$/Unit) by Type (2015-2020)
Table 50. Global Vaccine for Influenza Sales (K Units) by Application (2015-2020)
Table 51. Global Vaccine for Influenza Sales Market Share by Application (2015-2020)
Table 52. Global Vaccine for Influenza Sales Growth Rate by Application (2015-2020)
Table 53. Sanofi Vaccine for Influenza Corporation Information
Table 54. Sanofi Description and Business Overview
Table 55. Sanofi Vaccine for Influenza Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. Sanofi Main Product
Table 57. Sanofi Recent Development
Table 58. CSL Vaccine for Influenza Corporation Information
Table 59. CSL Corporation Information
Table 60. CSL Vaccine for Influenza Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. CSL Main Product
Table 62. CSL Recent Development
Table 63. GSK Vaccine for Influenza Corporation Information
Table 64. GSK Corporation Information
Table 65. GSK Vaccine for Influenza Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. GSK Main Product
Table 67. GSK Recent Development
Table 68. Mylan Vaccine for Influenza Corporation Information
Table 69. Mylan Corporation Information
Table 70. Mylan Vaccine for Influenza Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Mylan Main Product
Table 72. Mylan Recent Development
Table 73. Hulan Bio Vaccine for Influenza Corporation Information
Table 74. Hulan Bio Corporation Information
Table 75. Hulan Bio Vaccine for Influenza Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. Hulan Bio Main Product
Table 77. Hulan Bio Recent Development
Table 78. AstraZeneca Vaccine for Influenza Corporation Information
Table 79. AstraZeneca Corporation Information
Table 80. AstraZeneca Vaccine for Influenza Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. AstraZeneca Main Product
Table 82. AstraZeneca Recent Development
Table 83. CCBIO Vaccine for Influenza Corporation Information
Table 84. CCBIO Corporation Information
Table 85. CCBIO Vaccine for Influenza Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. CCBIO Main Product
Table 87. CCBIO Recent Development
Table 88. Sales Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Vaccine for Influenza Distributors List
Table 91. Vaccine for Influenza Customers List
Table 92. Market Key Trends
Table 93. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 94. Key Challenges
Table 95. Global Vaccine for Influenza Sales (K Units) Forecast by Type (2021-2026)
Table 96. Global Vaccine for Influenza Sales Market Share Forecast by Type (2021-2026)
Table 97. Global Vaccine for Influenza Revenue (Million US$) Forecast by Type (2021-2026)
Table 98. Global Vaccine for Influenza Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 99. Global Vaccine for Influenza Sales (K Units) Forecast by Application (2021-2026)
Table 100. Global Vaccine for Influenza Revenue (Million US$) Forecast by Application (2021-2026)
Table 101. Global Vaccine for Influenza Sales (K Units) Forecast by Region (2021-2026)
Table 102. Global Vaccine for Influenza Sales Market Share Forecast by Region (2021-2026)
Table 103. Global Vaccine for Influenza Revenue Forecast by Region (2021-2026) (US$ Million)
Table 104. Global Vaccine for Influenza Revenue Market Share Forecast by Region (2021-2026)
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Picture of Vaccine for Influenza
Figure 2. Global Vaccine for Influenza Sales Market Share by Type: 2020 VS 2026
Figure 3. Trivalent Influenza Vaccine Product Picture
Figure 4. Quadrivalent Influenza Vaccine Product Picture
Figure 5. Global Vaccine for Influenza Consumption Market Share by Application: 2020 VS 2026
Figure 6. For Children (6 months to 3 years)
Figure 7. For Adults and Children over 3 years
Figure 8. Global Vaccine for Influenza Market Size 2015-2026 (US$ Million)
Figure 9. Global Vaccine for Influenza Sales Capacity (K Units) (2015-2026)
Figure 10. Global Vaccine for Influenza Market Size Market Share by Region: 2020 Versus 2026
Figure 11. Vaccine for Influenza Sales Share by Manufacturers in 2020
Figure 12. Global Vaccine for Influenza Revenue Share by Manufacturers in 2019
Figure 13. The Global 5 and 10 Largest Players: Market Share by Vaccine for Influenza Revenue in 2019
Figure 14. Vaccine for Influenza Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global Vaccine for Influenza Sales Market Share by Region (2015-2020)
Figure 16. Global Vaccine for Influenza Sales Market Share by Region in 2019
Figure 17. Global Vaccine for Influenza Revenue Market Share by Region (2015-2020)
Figure 18. Global Vaccine for Influenza Revenue Market Share by Region in 2019
Figure 19. North America Vaccine for Influenza Sales Market Share by Country in 2019
Figure 20. North America Vaccine for Influenza Revenue Market Share by Country in 2019
Figure 21. U.S. Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 22. U.S. Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 23. Canada Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 24. Canada Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Europe Vaccine for Influenza Sales Market Share by Country in 2019
Figure 26. Europe Vaccine for Influenza Revenue Market Share by Country in 2019
Figure 27. Germany Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 28. Germany Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. France Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 30. France Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. U.K. Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 32. U.K. Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. Italy Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 34. Italy Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Russia Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 36. Russia Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Asia Pacific Vaccine for Influenza Sales Market Share by Region in 2019
Figure 38. Asia Pacific Vaccine for Influenza Revenue Market Share by Region in 2019
Figure 39. China Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 40. China Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Japan Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 42. Japan Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. South Korea Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 44. South Korea Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. India Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 46. India Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Australia Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 48. Australia Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Taiwan Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 50. Taiwan Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Indonesia Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 52. Indonesia Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Thailand Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 54. Thailand Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Malaysia Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 56. Malaysia Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Philippines Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 58. Philippines Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Vietnam Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 60. Vietnam Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Latin America Vaccine for Influenza Sales Market Share by Country in 2019
Figure 62. Latin America Vaccine for Influenza Revenue Market Share by Country in 2019
Figure 63. Mexico Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 64. Mexico Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Brazil Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 66. Brazil Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Argentina Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 68. Argentina Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Middle East and Africa Vaccine for Influenza Sales Market Share by Country in 2019
Figure 70. Middle East and Africa Vaccine for Influenza Revenue Market Share by Country in 2019
Figure 71. Turkey Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 72. Turkey Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Saudi Arabia Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 74. Saudi Arabia Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. U.A.E Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 76. U.A.E Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Sales Market Share of Vaccine for Influenza by Type (2015-2020)
Figure 78. Sales Market Share of Vaccine for Influenza by Type in 2019
Figure 79. Revenue Share of Vaccine for Influenza by Type (2015-2020)
Figure 80. Revenue Market Share of Vaccine for Influenza by Type in 2019
Figure 81. Global Vaccine for Influenza Sales Growth by Type (2015-2020) (K Units)
Figure 82. Global Vaccine for Influenza Sales Market Share by Application (2015-2020)
Figure 83. Global Vaccine for Influenza Sales Market Share by Application in 2019
Figure 84. Global Revenue Share of Vaccine for Influenza by Application (2015-2020)
Figure 85. Global Revenue Share of Vaccine for Influenza by Application in 2020
Figure 86. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Hulan Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. CCBIO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Price Trend of Key Raw Materials
Figure 94. Manufacturing Cost Structure of Vaccine for Influenza
Figure 95. Manufacturing Process Analysis of Vaccine for Influenza
Figure 96. Vaccine for Influenza Industrial Chain Analysis
Figure 97. Channels of Distribution
Figure 98. Distributors Profiles
Figure 99. Porter's Five Forces Analysis
Figure 100. North America Vaccine for Influenza Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 101. North America Vaccine for Influenza Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 102. Europe Vaccine for Influenza Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 103. Europe Vaccine for Influenza Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 104. Latin America Vaccine for Influenza Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 105. Latin America Vaccine for Influenza Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 106. Middle East and Africa Vaccine for Influenza Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 107. Middle East and Africa Vaccine for Influenza Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Asia Pacific Vaccine for Influenza Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 109. Asia Pacific Vaccine for Influenza Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed
Figure 1. Picture of Vaccine for Influenza
Figure 2. Global Vaccine for Influenza Sales Market Share by Type: 2020 VS 2026
Figure 3. Trivalent Influenza Vaccine Product Picture
Figure 4. Quadrivalent Influenza Vaccine Product Picture
Figure 5. Global Vaccine for Influenza Consumption Market Share by Application: 2020 VS 2026
Figure 6. For Children (6 months to 3 years)
Figure 7. For Adults and Children over 3 years
Figure 8. Global Vaccine for Influenza Market Size 2015-2026 (US$ Million)
Figure 9. Global Vaccine for Influenza Sales Capacity (K Units) (2015-2026)
Figure 10. Global Vaccine for Influenza Market Size Market Share by Region: 2020 Versus 2026
Figure 11. Vaccine for Influenza Sales Share by Manufacturers in 2020
Figure 12. Global Vaccine for Influenza Revenue Share by Manufacturers in 2019
Figure 13. The Global 5 and 10 Largest Players: Market Share by Vaccine for Influenza Revenue in 2019
Figure 14. Vaccine for Influenza Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global Vaccine for Influenza Sales Market Share by Region (2015-2020)
Figure 16. Global Vaccine for Influenza Sales Market Share by Region in 2019
Figure 17. Global Vaccine for Influenza Revenue Market Share by Region (2015-2020)
Figure 18. Global Vaccine for Influenza Revenue Market Share by Region in 2019
Figure 19. North America Vaccine for Influenza Sales Market Share by Country in 2019
Figure 20. North America Vaccine for Influenza Revenue Market Share by Country in 2019
Figure 21. U.S. Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 22. U.S. Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 23. Canada Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 24. Canada Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Europe Vaccine for Influenza Sales Market Share by Country in 2019
Figure 26. Europe Vaccine for Influenza Revenue Market Share by Country in 2019
Figure 27. Germany Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 28. Germany Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. France Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 30. France Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. U.K. Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 32. U.K. Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. Italy Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 34. Italy Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Russia Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 36. Russia Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Asia Pacific Vaccine for Influenza Sales Market Share by Region in 2019
Figure 38. Asia Pacific Vaccine for Influenza Revenue Market Share by Region in 2019
Figure 39. China Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 40. China Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Japan Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 42. Japan Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. South Korea Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 44. South Korea Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. India Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 46. India Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Australia Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 48. Australia Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Taiwan Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 50. Taiwan Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Indonesia Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 52. Indonesia Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Thailand Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 54. Thailand Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Malaysia Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 56. Malaysia Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Philippines Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 58. Philippines Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Vietnam Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 60. Vietnam Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Latin America Vaccine for Influenza Sales Market Share by Country in 2019
Figure 62. Latin America Vaccine for Influenza Revenue Market Share by Country in 2019
Figure 63. Mexico Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 64. Mexico Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Brazil Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 66. Brazil Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Argentina Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 68. Argentina Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Middle East and Africa Vaccine for Influenza Sales Market Share by Country in 2019
Figure 70. Middle East and Africa Vaccine for Influenza Revenue Market Share by Country in 2019
Figure 71. Turkey Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 72. Turkey Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Saudi Arabia Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 74. Saudi Arabia Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. U.A.E Vaccine for Influenza Sales Growth Rate (2015-2020) (K Units)
Figure 76. U.A.E Vaccine for Influenza Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Sales Market Share of Vaccine for Influenza by Type (2015-2020)
Figure 78. Sales Market Share of Vaccine for Influenza by Type in 2019
Figure 79. Revenue Share of Vaccine for Influenza by Type (2015-2020)
Figure 80. Revenue Market Share of Vaccine for Influenza by Type in 2019
Figure 81. Global Vaccine for Influenza Sales Growth by Type (2015-2020) (K Units)
Figure 82. Global Vaccine for Influenza Sales Market Share by Application (2015-2020)
Figure 83. Global Vaccine for Influenza Sales Market Share by Application in 2019
Figure 84. Global Revenue Share of Vaccine for Influenza by Application (2015-2020)
Figure 85. Global Revenue Share of Vaccine for Influenza by Application in 2020
Figure 86. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Hulan Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. CCBIO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Price Trend of Key Raw Materials
Figure 94. Manufacturing Cost Structure of Vaccine for Influenza
Figure 95. Manufacturing Process Analysis of Vaccine for Influenza
Figure 96. Vaccine for Influenza Industrial Chain Analysis
Figure 97. Channels of Distribution
Figure 98. Distributors Profiles
Figure 99. Porter's Five Forces Analysis
Figure 100. North America Vaccine for Influenza Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 101. North America Vaccine for Influenza Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 102. Europe Vaccine for Influenza Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 103. Europe Vaccine for Influenza Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 104. Latin America Vaccine for Influenza Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 105. Latin America Vaccine for Influenza Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 106. Middle East and Africa Vaccine for Influenza Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 107. Middle East and Africa Vaccine for Influenza Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Asia Pacific Vaccine for Influenza Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 109. Asia Pacific Vaccine for Influenza Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed
